Table 1

Demographics, histology, and autoantibody-associated phenomena for 17 patients with thymic neoplasm

PatientAge at diagnosis/sexAge at study enrollmentWHO classificationOpportunistic infectionsOther paraneoplastic conditionsNo. of anti-cytokine autoantibodies
34/M 40 B2 CMC, dVZV  
58/F 61 B2 CMC, S apiospermum, and M avium sinopulmonary disease  11 
18/F 23 B2  Myasthenia gravis, type 1 diabetes mellitus with anti–GAD-65 autoantibodies 
44/F 53 Thymoma*  Myasthenia gravis; eosinophilic fasciitis 
45/M 48 B2/B3 CMC Myasthenia gravis 
51/M 57 B3   
48/F 50 B1   
67/F 71   
36/M 45 B3 Disseminated cryptococcosis (lung, blood, liver) Coombs positive hemolytic anemia; Sweet syndrome 
10 34/F 35 B3  Myasthenia gravis 
11 36/M 42 B2/B3   
12 53/F 53   
13 41/F 41 B2   
14 27/M 31  Cushing syndrome 
15 39/M 39   
16 55/F 57 B3   
17 59/M 66 B3 dVZV  
PatientAge at diagnosis/sexAge at study enrollmentWHO classificationOpportunistic infectionsOther paraneoplastic conditionsNo. of anti-cytokine autoantibodies
34/M 40 B2 CMC, dVZV  
58/F 61 B2 CMC, S apiospermum, and M avium sinopulmonary disease  11 
18/F 23 B2  Myasthenia gravis, type 1 diabetes mellitus with anti–GAD-65 autoantibodies 
44/F 53 Thymoma*  Myasthenia gravis; eosinophilic fasciitis 
45/M 48 B2/B3 CMC Myasthenia gravis 
51/M 57 B3   
48/F 50 B1   
67/F 71   
36/M 45 B3 Disseminated cryptococcosis (lung, blood, liver) Coombs positive hemolytic anemia; Sweet syndrome 
10 34/F 35 B3  Myasthenia gravis 
11 36/M 42 B2/B3   
12 53/F 53   
13 41/F 41 B2   
14 27/M 31  Cushing syndrome 
15 39/M 39   
16 55/F 57 B3   
17 59/M 66 B3 dVZV  

CMC indicates chronic mucocutaneous candidiasis; and dVZV, disseminated varicella zoster virus

*

World Health Organization (WHO) classification not available.

Close Modal

or Create an Account

Close Modal
Close Modal